Relapsed & Refractory Blood Cancers

AVM Biotechnology > Our Focus > Relapsed & Refractory Blood Cancers
AVM0703 Is As Effective Against Lymphoma As Chemotherapy with Reduced Toxicities

Below is the table summarizing AVM0703 efficacy and safety against lymphoma compared to chemotherapy: 

Mouse A20 Lymphoma Model AVM0703 Chemotherapy

Number of Lymphoma Cells Inoculated

2M Cells (More Aggressive) 1M Cells

Body Weight Changes

20% weight loss max 30% weight loss

Mouse Death

None 18% of mice